The expression of antimicrobial peptides at epithelial surfaces such as skin, lung, and intestine is thought to provide protection against infection. Cathelicidin antimicrobial peptides are essential for the protection of skin against invasive bacterial infection. To determine if cathelicidins are also present in the oral cavity, we examined the expression of both mRNA and protein in mice and human saliva. The murine cathelicidin (CRAMP) was detected in the adult by reverse-transcription/polymerase chain-reaction (RT-PCR), and in embryonic, newborn, and adult tissues by in situ hybridization and immunohistochemistry. CRAMP mRNA and protein were localized to the salivary glands, specifically in acinar cells of the submandibular gland and palatine minor glands, as well as in lingual epithelium and palatal mucosa. In man, the human cathelicidin LL-37 was detected in human saliva by Western blotting. These results indicate that cathelicidins are present in the salivary system, in some oral epithelia, and in saliva, contributing to broad-spectrum defense of the oral cavity.
Get full access to this article
View all access options for this article.
References
1.
Agerberth B, Gunne H, Odeberg J, Kogner P, Boman HG, Gudmundsson GH -1995-. FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc Natl Acad Sci USA92:195–199.
2.
Bals R -2000-. Epithelial antimicrobial peptides in host defense against infection. Respir Res1:141–150.
3.
Bals R, Wang X, Zasloff M, Wilson JM -1998-. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc Natl Acad Sci USA95:9541–9546.
4.
Dale BA, Krisanaprakornkit S -2001-. Defensin antimicrobial peptides in the oral cavity. J Oral Pathol Med30:321–327.
5.
Dale BA, Kimball JR, Krisanaprakornkit S, Roberts F, Robinovitch M, O'Neal R, et al. -2001-. Localized antimicrobial peptide expression in human gingiva. J Periodontal Res36:285–294.
6.
Dorschner RA, Pestonjamasp VK, Tamakuwala S, Ohtake T, Rudisill J, Nizet V, et al. -2001-. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Invest Dermatol117:91–97.
7.
Dunsche A, Acil Y, Siebert R, Harder J, Schroder JM, Jepsen S -2001-. Expression profile of human defensins and antimicrobial proteins in oral tissues. J Oral Pathol Med30:154–158.
8.
Eversole LR, Miyasaki KT, Christensen RE -1993-. Keratinocyte expression of calprotectin in oral inflammatory mucosal diseases. J Oral Pathol Med22:303–307.
9.
Frohm M, Agerberth B, Ahangari G, Stahle-Backdahl M, Liden S, Wigzell H, et al. -1997-. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem272:15258–15263.
10.
Frohm Nilsson M, Sandstedt B, Sorensen O, Weber G, Borregaard N, Stahle-Backdahl M -1999-. The human cationic antimicrobial protein -hCAP18-, a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infect Immun67:2561–2566.
11.
Gallo RL, Kim KJ, Bernfield M, Kozak CA, Zanetti M, Merluzzi L, et al. -1997-. Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse. J Biol Chem272:13088–13093.
12.
Gudmundsson GH, Agerberth B, Odeberg J, Bergman T, Olsson B, Salcedo R -1996-. The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur J Biochem238:325–332.
13.
Guthmiller JM, Vargas KG, Srikantha R, Schomberg LL, Weistroffer PL, McCray PB Jr, et al. -2001-. Susceptibilities of oral bacteria and yeast to mammalian cathelicidins. Antimicrob Agents Chemother45:3216–3219.
14.
Huttner KM, Bevins CL -1999-. Antimicrobial peptides as mediators of epithelial host defense. Pediatr Res45:785–794.
15.
Johansson J, Gudmundsson GH, Rottenberg ME, Berndt KD, Agerberth B -1998-. Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J Biol Chem273:3718–3724.
16.
Lehrer RI, Ganz T -2002a-. Defensins of vertebrate animals. Curr Opin Immunol14:96–102.
17.
Lehrer RI, Ganz T -2002b-. Cathelicidins: a family of endogenous antimicrobial peptides. Curr Opin Hematol9:18–22.
18.
Mathews M, Jia HP, Guthmiller JM, Losh G, Graham S, Johnson GK, et al. -1999-. Production of beta-defensin antimicrobial peptides by the oral mucosa and salivary glands. Infect Immun67:2740–2745.
19.
Miyasaki KT, Bodeau AL, Selsted ME, Ganz T, Lehrer RI -1990-. Killing of oral, Gram-negative, facultative bacteria by the rabbit defensin, NP-1. Oral Microbiol Immunol5:315–319.
20.
Nagaoka I, Hirota S, Yomogida S, Ohwada A, Hirata M -2000-. Synergistic actions of antibacterial neutrophil defensins and cathelicidins. Inflamm Res49:73–79.
21.
Nizet V, Ohtake T, Lauth X, Trowbridge J, Rudisill J, Dorschner RA, et al. -2001-. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature414:454–457.
22.
Oppenheim FG, Xu T, McMillian FM, Levitz SM, Diamond RD, Offner GD, et al. -1988-. Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans. J Biol Chem263:7472–7477.
23.
Pestonjamasp VK, Huttner KH, Gallo RL -2001-. Processing site and gene structure for the murine antimicrobial peptide CRAMP. Peptides22:1643–1650.
24.
Putsep K, Carlsson G, Boman HG, Anderson M -2002-. Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet360:1144–1149.
25.
Sahasrabudhe KS, Kimball JR, Morton TH, Weinberg A, Dale BA -2000-. Expression of the antimicrobial peptide, human beta-defensin 1, in duct cells of minor salivary glands and detection in saliva. J Dent Res79:1669–1674.
26.
Tanaka D, Miyasaki KT, Lehrer RI -2000-. Sensitivity of Actinobacillus actinomycetemcomitans and Capnocytophaga spp. to the bactericidal action of LL-37: a cathelicidin found in human leukocytes and epithelium. Oral Microbiol Immunol15:226–231.
27.
Tobgi RS, Samaranayake LP, MacFarlane TW -1988-. In vitro susceptibility of Candida species to lysozyme. Oral Microbiol Immunol3:35–39.
28.
Turner J, Cho Y, Dinh NN, Waring AJ, Lehrer RI -1998-. Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob Agents Chemother42:2206–2214.
29.
vanderSpek JC, Offner GD, Troxler RF, Oppenheim FG -1990-. Molecular cloning of human submandibular histatins. Arch Oral Biol35:137–143.
30.
Weinberg A, Krisanaprakornkit S, Dale BA -1998-. Epithelial antimicrobial peptides: review and significance for oral applications. Crit Rev Oral Biol Med9:399–414.
31.
Yang D, Chertov O, Oppenheim JJ -2001-. Participation of mammalian defensins and cathelicidins in anti-microbial immunity: receptors and activities of human defensins and cathelicidin -LL-37-. J Leukoc Biol69:691–697.
32.
Zanetti M, Gennaro R, Romeo D -1995-. Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett374:1–5.
33.
Zasloff M -2002-. Antimicrobial peptides of multicellular organism. Nature415:389–395.
34.
Zhao C, Wang I, Lehrer RI -1996-. Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett396:319–322.
